State of Wisconsin Investment Board’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

State of Wisconsin Investment Board’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-16,500	Closed	-$302K	–	2115
2020 Q4	$302K	Sell	16,500 -2,100	-11%	-$38.3K	﹤0.01%	1853
2020 Q3	$340K	Hold	18,600	–	–	﹤0.01%	1629
2020 Q2	$272K	Hold	18,600	–	–	﹤0.01%	1574
2020 Q1	$280K	Buy	18,600 +400	+2%	+$6.46K	﹤0.01%	1512
2019 Q4	$294K	Hold	18,200	–	–	﹤0.01%	1547
2019 Q3	$265K	Buy	18,200 +2,100	+13%	+$28.3K	﹤0.01%	1469
2019 Q2	$237K	Buy	16,100 +400	+3%	+$6.53K	﹤0.01%	1471
2019 Q1	$266K	Buy	15,700 +3,600	+30%	+$65.3K	﹤0.01%	1437
2018 Q4	$207K	Hold	12,100	–	–	﹤0.01%	1453
2018 Q3	$218K	Buy	+12,100	New	+$248K	﹤0.01%	1496

State of Wisconsin Investment Board's CBMG Position: Q1 2021 in Review

State of Wisconsin Investment Board sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 16,500 shares — an estimated $302K sold.

State of Wisconsin Investment Board first reported a position in CBMG in Q3 2018 and held it in 10 quarters. The position peaked at $340K in Q3 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

State of Wisconsin Investment Board reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 16,500 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $302K.
State of Wisconsin Investment Board first reported a position in Cellular Biomedicine Group, Inc. in Q3 2018 and held it in 10 quarters.
State of Wisconsin Investment Board's Cellular Biomedicine Group, Inc. position peaked at $340K in Q3 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2021, filed 17 May 2021.